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Management of early (30 day) vascular groin
infections using vacuum-assisted closure alone
without muscle flap coverage in a consecutive
patient series
Hasan H. Dosluoglu, MD,a,b Cyrus Loghmanee, MD,b Purandath Lall, MBBS,a
Gregory S. Cherr, MD,b Linda M. Harris, MD,b and Maciej L. Dryjski, MD,b Buffalo, NY
Objective: Vacuum-assisted closure (VAC) therapy without muscle flap coverage is our primary approach for graft
preservation in early, deep groin infections with and without exposed grafts; however, concerns exist regarding its safety.
We report our experience in a consecutive series of patients with early groin infections managed without muscle flap
closure.
Methods: All patients with early (<30 day), deep vascular groin infections without (Szilagyi II) or with (Szilagyi III)
exposed vascular graft or suture line between January 2004 and December 2008 were reviewed. Graft preservation
followed by local wound care with VAC was attempted in all with intact anastomoses, patent grafts, and absence of
systemic sepsis. Szilagyi classification, microorganism cultured, duration of VAC use, time to healing, additional
interventions, and follow-up data (limb salvage, survival) were analyzed.
Results: Twenty-two patients (26 groins, mean age 69.1  9.5 years [range, 44-86 years]) presented with deep groin
infections 16 5 days (range, 7-28 days) after the index procedure (bypass-polytetrafluoroethylene [n 11], autologous
vein [n 3], endarterectomy/patch [n 6], extra-anatomic bypass [n 5], percutaneous closure device [n 1]). Grafts
were exposed in 12 groins (Szilagyi III, nine with suture lines). VAC was started one to six days (median, three) after
operative debridement. All had positive wound cultures and received culture-directed antibiotic therapy for 47 45 days
(range, 14-180 days). Length of stay was significantly more in Szilagyi III, whereas mean VAC use and time-to-healing
were similar. Mean follow-up was 33.4  19.5 months (range, 2-72 months). All wounds healed (mean, 49  21 days).
Two treatment failures occurred in the Szilagyi III group (17%). One patient had bleeding from the anastomotic heel
eight days after debridement, had graft removal/in situ replacement and one presented with reinfection on day 117 and
had partial graft removal/extra-anatomic bypass. There was no perioperative mortality or limb loss, but six late unrelated
mortalities and one amputation at 46 months unrelated to the groin infection.
Conclusions:Management of early, deep groin wound infections with debridement, antibiotics, and VAC treatment is safe
and enables graft preservation in the majority of patients with minimal morbidity, no perioperative limb loss, or
mortality. ( J Vasc Surg 2010;51:1160-6.)Groin incisions play a central role in various vascular
surgical reconstructions and have gained widespread use with
the adoption of endovascular aneurysm repairs, and complex
hybrid reconstructions for atherosclerotic occlusive disease
in addition to their traditional use in bypass procedures,
endarterectomies, and access procedures. However, groin
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1160incisions may be complicated by wound dehiscence, lym-
phatic fistula or infections in 5% to 10% of patients follow-
ing these procedures.1-3 After vascular surgery, groin com-
plications may be limb- or life-threatening, especially for
early, deep wound infections.
The initial treatment of early deep groin infections
includes surgical debridement and antibiotics. Manage-
ment of patients with exposed synthetic grafts is especially
challenging. Graft excision and extra-anatomic or in situ
bypass or patch replacement using autologous, rifampin-
soaked, or silver-impregnated materials have been used.
However, due to the high morbidity and mortality associ-
ated with these operations, various graft preservation tech-
niques have been increasingly utilized in an attempt to
improve outcomes.4-6
Graft preservation may be considered when the anasto-
mosis is intact, the whole graft is not involved with infec-
tion, the patient has no systemic signs of sepsis, the graft is
patent and the offending organism is not Pseudomonas
aeruginosa.7,8 Aggressive debridement, intravenous antibi-
otics, and various muscle flaps have been widely reported
and are currently the most commonly used treatment in
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be feasible in some patients (such as high perioperative risk,
malnutrition, or severely scarred groins) and is reported to
have a reinfection rate between 0% and 35%.5,6,8-10 Local
wound care without muscle flap closure has been reported
in patients who are poor operative candidates with a greater
than 75% initial success rate.11,12
Treatment of deep groin wound infections with
vacuum-assisted closure systems (VAC) with13,14 or with-
out muscle flap coverage15-20 has been reported, including
our initial experience in four patients with exposed grafts
who were successfully treated with no reinfections to
date.20 Although four15,16,18,20 of the five reported studies
for the management of groin infections with exposed
grafts did not report any early or late bleeding or infec-
tious complications, Svensson et al19 reported one early
bleeding and three late false aneurysms after using VAC
therapy in patients with groin infections and cautioned
for this complication with the use of VAC therapy in
these patients. Brehm et al21 also reported a patient who
developed massive bleeding with VAC therapy for groin
infection after axillary-bifemoral bypass.
We have been primarily using VACwithout muscle flap
coverage following aggressive debridement in patients who
develop early postoperative deep groin infections with or
without graft or suture line exposure following our initial
favorable experience,20 and the goal is to report our expe-
rience in a consecutive patient series.
MATERIAL AND METHODS
All patients who developed deep groin infections
requiring operative debridement without (Szilagyi II) or
with graft involvement (Szilagyi III)22 30 days follow-
ing vascular procedures in whom a graft preservation was
attempted in Veterans Administration Western New York
Healthcare System between September 2003 and August
2008 were included in our analysis. Patients who presented
with late (30 days) graft infections (n 7) and those who
had superficial wound dehiscence managed with
local wound care only or cellulitis treated with oral antibi-
otics were excluded. Patients with noninfected seromas,
hematomas, or other wound problems were also not in-
cluded in this series. Patient demographics, the initial indi-
cation for intervention, type of intervention, type of graft
materials used, time to first presentation with groin infec-
tion, the second procedure performed, time to VAC place-
ment, length of stay, duration of VAC use, time to com-
plete healing, and follow-up information (the condition of
the groin, graft, ipsilateral limb, and overall health) were
recorded.
When patients were diagnosed with an early, deep
groin infection, blood and wound cultures were obtained
along with white blood cell count, and they were started
empirically on intravenous broad-spectrum antibiotics
(vancomycin plus piperacillin/tazobactam, or ciprofloxacin
in those with penicillin allergy). When possible, patients
underwent imaging to determine the extent of infection,
followed by operative debridement (Fig 1, A) and deepwound culture. Patients’ wounds were assessed daily during
the dressing change using ionic silver-containing gel. The
VAC system was applied when the wound was free of
necrotic or infected tissue and hemostatic (one to six days
after operative debridement). The VAC was set on contin-
uous negative pressure of 125 mm Hg. If the anastomosis
was exposed, a nonadhering dressing (Kendall, Curity,
Tyco Healthcare, Mansfield, Mass) was used to keep the
anastomosis from coming in direct contact with the
sponge. The VAC sponges were changed three times a
week, (Fig 1B-D) and minor bedside debridements were
performed during sponge change when needed, two to
three times per patient. No patients required debridements
in the OR after initiation of VAC therapy. All patients were
kept on culture-directed intravenous antibiotics for 2 to 26
weeks, depending on the presence of exposed anastomosis
or prosthetic graft and the virulence of the cultured bacte-
ria.
The patients with exposed grafts or anastomoses were
kept in the hospital until the exposed graft was completely
covered with granulation tissue. Patients without graft
exposure were kept in the hospital until the base of the
wound showed healthy granulation tissue formation and
did not need further debridements during VAC sponge
changes. All patients were followed in our vascular surgery
wound clinic until the wounds were completely healed.
None of the wounds required skin grafting. Patients were
then followed in our vascular surgery clinic at threemonths,
six months and every six months thereafter. Only two
patients in our series had CT examinations 6 and 12
months after the groin infection, both of whom had no
signs of persistent/recurrent infection. All other patients
underwent clinical examination, in addition to the routine
vascular graft follow-up by our vascular laboratory.
Data analysis was performed using SPSS 16.0 software
(SPSS Inc, Chicago, Ill). Demographic comparisons were
made using two-tailed Fisher’s exact test for categorical
variables, and t-test for continuous variables. Institutional
Review Board approval was obtained for the study.
RESULTS
There were 22 patients (26 groins) who had Szilagyi II
(14 groins) or Szilagyi III (12 groins) infections. Four of
the patients included in this series were previously re-
ported.20,23 Four patients had bilateral groin involve-
ment, two of whom had bilateral Szilagyi II infections,
and two with Szilagyi II and III infections in each groin. All
patients were males (mean age 69.1  9.5 years [range,
44-86 years] with no difference between groups). The
comorbidities and indications for intervention are listed in
Table I. Patients were classified as American Society of
Anesthesiologists (ASA) 3 (67%) or ASA 4 (33%). Most
procedures were performed for critical limb ischemia
(73%), while one patient had femoral patching after endo-
vascular stent graft repair of an abdominal aortic aneurysm.
The initial procedures performed are listed on Table II.
Twenty groins had polytetrafluoroethylene (PTFE) grafts,
two had bovine pericardial patches, three had autologous
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braided suture from the closure device on the femoral
artery. In the Szilagyi 3 group, 10 patients had PTFE grafts,
one had autologous vein, and one patient had an infected
pseudoaneurysm with the braided suture with exposed
prolene at the base of the wound following primary repair
of the femoral artery.
The time to presentation with infection ranged from 7
to 28 days (mean, 16  5 days). The deep groin wound
Fig. Early wound breakdown after a redo femoral-po
occlusion in a 68-year-old patient with diabetes and heel
four days after VAC was started, C) 16 days after initial
healed completely on day 35 (not shown).
Table I. Comorbidities, indications for intervention
Comorbidity/indication %
Coronary artery disease 82%
Hypertension 91%
Diabetes mellitus 50%
Chronic obstructive pulmonary disease 41%
Smoker (active) 36%
Hyperlipidemia 86%
Renal insufficiency 41%
Dialysis 14%
Indication
Claudication 23%
Rest pain 32%
Tissue loss 41%
Abdominal aortic aneurysm 4%infection was preceeded by lymphorrhea in two patientsand wound breakdown in three patients. Fourteen of the
groins did not have exposed grafts following debridement
(Szilagyi II), and the remaining 12 had Szilagyi III infec-
tions. In 9 of the 12 Szilagyi III infections, at least part of
the anastomosis was exposed after debridement. Fourteen
of the 22 patients had CT scans before debridement, show-
ing perigraft fluid with (n 4) or without perigraft air (n
5) in 9 of the 12 patients in the Szilagyi III group and
pseudoaneurysm in one. None of the patients in this group
had perigraft fluid outside the groin. For the five with
Szilagyi II infections who had CT scans, the CT demon-
l bypass with a PTFE graft and iliac stenting for iliac
rene. A) After the initial debridement, B) six days later,
ement, and D) 23 days after debridement. The wound
Table II. List of initial operations
Initial operation N (%)
Femoropopliteal/distal bypass
With PTFE 11 (42.3%)
With vein 3 (11.5%)
Femoro-femoral bypass with PTFE 3 (11.5%)
Axillary-bifemoral bypass with PTFE 2 (7.6%)
Femoral endarterectomy with patch
PTFE 3 (11.5%)
Bovine pericardium 2 (7.6%)
EVAR, with PTFE patch closure of CFA 1 (3.8%)
Percutaneous SFA intervention with closure device 1 (3.8%)
CFA, Common femoral artery; EVAR, endovascular aneurysm repair;
PTFE, polytetrafluoroethylene; SFA, superficial femoral artery.plitea
gang
debridstrated the absence of graft involvement in all patients.
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each group. The white blood cell count at presentation was
13.2  7.1/mm3 in the Szilagyi II group, and 11.9 
7.0/mm3 in the Szilagyi III group (P .630), with 54% of
patients in Szilagyi II and 50% of patients in Szilagyi III
being 10K. The culture results are shown in Table III.
The majority of the infections were polymicrobial. Pseudo-
monas aeruginosa was isolated from two groins, one of
which was also infected with Escherichia coli, and Entero-
coccus faecalis. Only one patient had positive blood cultures
for methicillin-sensitive Staphylococcus aureus, who was the
first patient treated in this series.23
The time to VAC was 3.0  1.8 days in the Szilagyi II
and 2.1  0.9 days in the Szilagyi III groups (P  .197).
The duration of VAC use ranged from 6 to 53 days and was
28  12 days in the Szilagyi II and 26  15 days in the
Szilagyi III group (P  .684). The hospital length of stay
was significantly longer in patients with Szilagyi III infec-
tions (10  13 days vs 20.5  13 days, P  .04). Wound
healing was achieved in 49  20 days (range, 7-100 days),
with no difference between groups (P  .772).
There were two failures (one early, one late) in the
Szilagyi III group. The first was an 86-year-old patient with
diabetes, coronary artery disease, hypertension, and de-
mentia, who presented with left limb ischemia one year
after endovascular repair of his 7-cm aneurysm and under-
went a femoro-femoral bypass with an 8-mm ringed PTFE
graft. He developed bilateral wound breakdown, fever
(39°C), and leukocytosis (27,900/mm3). After initiation
of broad-spectrum antibiotic therapy, his wounds were
debrided with exposure of the right groin anastomosis (but
not the left anastomosis). VAC therapy was started the
following day, and his wounds were improving. His right
groin culture grew Enterococcus fecalis, Escherichia coli, and
Pseudomonas aeruginosa, whereas his left groin grew Pro-
teus mirabilis. He developed a sudden bleeding from his
right groin eight days after the debridement and was emer-
gently taken to the OR. The bleeding was noted from the
anastomotic heel and was repaired with 5/0 prolene su-
tures. After he was stabilized overnight, we removed the
graft the next day and replaced it with a cryopreserved
femoral vein graft (8-10 mm diameter) after arterial anas-
Table III. Culture results from wounds
Culture result N
Polymicrobial 11*
Methicillin-resistant Staphylococcus aureus 3
Methicillin-sensitive Staphylococcus aureus 4
Pseudomonas 1
Escherischia coli 1
Proteus mirabilis 2
Enterococci 1
Vancomycin-resistant enterococcus 1
Klebsiella 1
Enterobacter cloacae 1
*One patient had Pseudomonas.tomotic debridement. He was discharged to a rehabilita-tion facility 35 days later, and the wounds were both healed
on 55 days. He died seven months later in a nursing home
with a CT and duplex result showing a normal graft with no
signs of infection one month prior to his demise. This case
was previously reported as part of a technique descrip-
tion.23
The second patient is a 59-year-old male with congestive
heart failure, coronary artery disease, and chronic obstructive
pulmonary disease who had an axillary-bifemoral bypass for a
failed aortobifemoral bypass. Three and a half years later, he
presented with an occluded axillary-bifemoral graft and rest
pain and underwent thrombolysis, followed by bilateral
patch angioplasties (PTFE) of the femoral anastomoses. He
subsequently developed a right groin infection, which was
debrided 16 days after the graft revision. The wound cul-
ture grew Pseudomonas aerigunosa. VACwas started on the
following day, and was kept for 20 days, and he completely
healed his wound in 30 days, and was kept on intravenous
antibiotics for three months. He presented on the 117th
day with recurrent groin infection, underwent debridement
with partial graft removal, and a bypass to his above-knee
popliteal artery using a heparin-bonded PTFE graft origi-
nating from the afferent limb of the axillary-bifemoral graft.
His wound completely healed in 35 days, and is currently
free of disease during his last visit 18 months after the last
procedure.
Mean follow-up was 33.4 19.5 months (range, 2-72
months). The overall success rate was 100% in the Szilagyi
II group and 83% for the Szilagyi III group on an intent-
to-treat basis. There was no perioperative mortality, and all
wounds were eventually healed. One amputation occurred
in a patient at 49 months, unrelated to the groin infection.
There were no late infections, and there were six unrelated
mortalities during the follow-up period.
DISCUSSION
Groin infections following vascular procedures are not
uncommon, and the presence of synthetic grafts in the
open wound presents even more of a challenge for the
vascular surgeon. Graft preservation in patients with early
postoperative groin wound complications is attempted in
the majority of these patients, and the use of muscle flaps
has been successfully used for this purpose, which was
reported to be particularly effective in early groin infec-
tions.5,10 However, use of the muscle flap does not guar-
antee a successful outcome, and muscle flap necrosis and
reinfection with resultant failure has been reported to occur
in up to 35% of patients.9 In addition, mortality rates up to
25% have been reported,6 mostly due to the poor overall
condition of the patients. Extremely scarred groins and
poor nutritional status may also become significant issues
when major surgical reinterventions are contemplated in
these poor-risk patients. Seify et al8 reviewed the manage-
ment of prosthetic graft infections in studies reported be-
tween 1989 and 2004, encompassing 223 patients, 70% of
whom were managed with graft preservation and 74% with
muscle flap coverage. The mortality rate was 11%, limb loss
was 13%, and of the initially preserved grafts, 12% later
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graft, and Pseudomonas infection being associated with
poorer graft salvage rates and higher amputation rates.
Local wound care without the use of muscle flaps has
been used with reasonable amputation and perioperative
mortality rates. Calligaro et al11 reported a 12% mortality
and 4% amputation rate in 51 patients with infected pros-
thetic grafts, about 71% of which could be preserved suc-
cessfully by using repeated operative debridement and an-
tibiotic or povidone-iodine-soaked dressings. After the
initial description of the vacuum-assisted therapy for
wound care, the VAC therapy has been widely adopted by
vascular surgeons, and its use in groin wounds with lym-
phorrhea24 or wound infections inevitably followed, even
in those with exposed grafts, although this is not recom-
mended by the manufacturer.25 Successful VAC use has
been reported following infected pseudoaneurysm of the
femoral artery following primary or patch closure15 and
exposed vein grafts,26 as well as those who had synthetic
patch or grafts in the groins with no bleeding or reinfec-
tions.16,18,20 Pinocy et al16 reported the use of PVA-
vacuum sponge system in 24 patients with Szilagyi III
wound infections, 18 of whom had synthetic patches fol-
lowing endarterectomies and six of whom had aortob-
ifemoral bypass grafts. They used a closed suction system in
which they closed the wounds over the sponge system that
was connected to a Redon drain, and applied 400 to 600
mmHg negative pressure. They re-explored the wounds at
seven days and replaced the sponge, and the wounds were
finally primarily closed after another week. They reported
no reinfections at 12 months. Our group20 also reported
four patients with groin infections and exposed synthetic
grafts successfully treated with debridement and VAC,
without further surgical procedures. In another large series
presented (unpublished) by Mayer et al,27 44 patients (52
sites) with perivascular infections or lymphatic leaks were
treated with the VAC system, with a 100% success rate, no
rebleeding or reinfections, and a mean VAC application
time of 34 days. They applied the VAC sponges directly on
the vessels without any problems. Kotsis et al18 successfully
treated eight patients (six of whom had Szilagyi III infec-
tions) with early groin infections with 100% success; no
rebleeding or reinfections were reported. However, bleed-
ing from the exposed anastomosis has been reported.19,21
Svensson et al19 recently reported two early bleeding and
three late infected pseudoaneurysms in 33 patients with
vascular groin infections treated by VAC. These authors
hypothesized that the early bleeding was probably inevita-
ble and was likely due to residual infection at the suture
lines, and may have been hastened by the use of the VAC.
After our initial favorable experience with the use of
VAC without muscle flap coverage for early groin infec-
tions,20 we started to use this method preferentially with
continued success. We found that the use of VAC in
patients with deep groin infections without an exposed
graft was very effective. The wounds treated in our series
were large, and the time to healing was not different than
those with exposed grafts. However, the length of stay wassignificantly less in this subgroup than those with exposed
grafts, and there was no bleeding or other wound healing
problems. We feel that patients who have exposed grafts
should be kept in the hospital until the grafts are not visible
at the base of the wounds. The one patient who hadmassive
bleeding in our series bled from the heel of the anastomosis
while in the hospital, and the outcome would have been
much worse had this occurred outside the hospital. Of
note, the bleeding site was clearly not in direct contact with
the sponge but was likely due to the residual infection at the
anastomosis. This patient had pseudomonas as part of a
polymicrobial infection in the groin that bled. Replacement
of the graft with an in situ cryopreserved vein graft was
successful, achieving complete wound healing. The second
patient who failed also had Pseudomonas aeruginosa, and in
retrospect, should probably not have had graft salvage
attempt. Although some authors did not observe worse
outcomes with Pseudomonas infection,5,10 others have re-
ported increased amputation rates or poorer graft sal-
vage.7,8,31 Calligaro et al7 reported only 40% graft salvage
when the offending organism was Pseudomonas. Pseudomo-
nas infection was associated with 60% limb loss in a series
reported by Seify et al.8 Since both our patients with
Szilagyi III infections with Pseudomonas infections eventu-
ally needed graft removal, we now recommend graft re-
moval in early Pseudomonas groin infections with exposed
grafts.
Almost all patients who had bleeding or reinfection in
the reported series19,21 had significant graft infection and
were likely poor case selections for any type of graft preser-
vation, as did both of our cases with Pseudomonas infec-
tions. Patients who have infected pseudoaneurysms or any
history of bleeding, suggesting that the anastomosis is not
intact, are likely not candidates for any graft preservation
techniques, including muscle flaps. We think that the early
groin infections in the patients in our series mostly repre-
sent a wound infection with graft present, rather than an
early or late graft infection presenting as an infected pseu-
doaneurysm or wound infection localized to the groin. We
think that the latter are poorer candidates for any type of
graft preservation techniques, and we favor graft removal
with either in situ replacement or extra-anatomic bypass in
these patients.
It is important to differentiate between early and late
graft infections when making a treatment choice for pa-
tients with groin infections. In the series by Perler et al5
involving muscle flaps for graft preservation, all grafts with
acute presentations were successfully salvaged, whereas it
was 60% in the chronic group. Mertens et al28 reported a
very high (82%) failure rate, when anything less than total
excision was used. Taylor et al9 reported that six out of nine
patients with muscle flaps had recurrent infection, in a
group of early and late infections. Calligaro et al29 reported
that even though there was no difference in amputation or
mortality rates between early (two months) or late graft
infections, early graft infections were more likely to be
treated by complete graft preservation (61% vs 26%, P 
.0001). All the patients successfully treated with VAC in
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our previous series were in patients with acute infections,
and the series by Svensson et al19 included patients with
early and late infections, and the timing of presentation was
not specified in the patients who had failures. However,
there have clearly been some early failures reported in early
groin infections, including one patient in our series, and the
patient reported by Brehm et al.21 The importance of
repeated wound inspections and application of the VAC
after confirmation that all bleeding has stopped, and there
is no grossly obvious residual infection in the wound cannot
be overemphasized, sincemost of the early failures are likely
due to residual infection at the anastomosis, which leads to
the bleeding in these patients. Eradication of infections
from chronic graft infections is less likely to be successful
by VAC alone, and graft excision with in situ or extra-
anatomic bypass procedures coupled with selective use of
muscle flaps would be the treatment of choice in these
patients. We performed partial or total graft excision in all
patients who presented with late graft infections during the
study period (data not shown). Armstrong et al30 recently
reported their experience with the selective application of
muscle flaps in mostly late (90%) graft infections, and graft
preservation was attempted in only 3 of the 89 patients.
In conclusion, VAC in early groin infections following
radical debridement, combined with culture-directed anti-
biotics is safe (intact anastomosis, patent graft, no sepsis,
no pseudomonas) and can be considered as an alternative
to muscle flap, especially in high-risk patients with fi-
brotic groins and/or poor nutritional status. It is associ-
ated with minimal morbidity, reinfection, limb loss, and
mortality. VAC can be used in patients with exposed
grafts/suture line, but close monitoring is necessary for
possible bleeding, which is likely due to residual infec-
tion at the anastomotic line. Finally, Pseudomonas infec-
tion is a relative contraindication for graft preservation;
graft removal with reconstruction should be considered
early in these cases.
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